Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 46
Filtrar
Mais filtros

Intervalo de ano de publicação
1.
Pediatr Dermatol ; 32(6): 786-91, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26477326

RESUMO

Pityriasis alba (PA) is a skin disorder that affects children and adolescents. Although it is common worldwide, its incidence is markedly higher in darker skin phototypes. Its characteristic features include an extended, multistage course and spontaneous remissions and recurrences. Preceded by erythematous changes, patches of hypopigmented skin of up to a few centimeters in diameter appear on the upper body. Pruritus may accompany it. Even though its etiology is unknown, possible reported triggering factors include sunlight, beauty treatments, and microorganisms, among others. Calcineurin inhibitors play the most crucial role in PA pharmacotherapy. PA often coexists with atopic dermatitis and is considered one of its milder forms.


Assuntos
Imunossupressores/uso terapêutico , Terapia com Luz de Baixa Intensidade/métodos , Pitiríase/patologia , Pitiríase/terapia , Administração Cutânea , Adolescente , Fatores Etários , Biópsia por Agulha , Criança , Pré-Escolar , Doença Crônica , Fármacos Dermatológicos/uso terapêutico , Progressão da Doença , Feminino , Humanos , Imuno-Histoquímica , Masculino , Pitiríase/fisiopatologia , Prognóstico , Medição de Risco , Índice de Gravidade de Doença , Fatores Sexuais , Resultado do Tratamento
3.
Niger Postgrad Med J ; 21(2): 196-8, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-25167599

RESUMO

Pityriasis amiantacea (PA) is a papulosquamous condition of the scalp,characterized by asbestos - like thick scales attached to the hair shaft. It is thought to represent a reaction pattern to inflammatory skin disorders like psoriasis, seborrhoeic dermatitis, tinea capitis, atopic dermatitis and lichen planus, rather than a distinctive disease. The scaling may be localised or generalised, depending on the underlying condition and its duration.This report highlights the clinical features of pityriasis amiantacea secondary to atopic dermatitis and the differential features of other papulo-squamous scalp disorders such as scalp psoriasis, seborrhoeic dermatitis and lichen planus.Scalp psoriasis and seborrhoeic dermatitis are the commonest causes of PA as well as the closest differentials hence should be excluded in all cases. The longterm sequelae of PA include scalp fibrosis and permanent hair loss hence should be identified and treated promptly. The management modalities of PA will also be discussed.


Assuntos
Pitiríase/diagnóstico , Pitiríase/terapia , Dermatoses do Couro Cabeludo/etiologia , Adolescente , Feminino , Humanos , Pitiríase/etiologia , Dermatoses do Couro Cabeludo/diagnóstico , Dermatoses do Couro Cabeludo/terapia
5.
Cutis ; 87(2): 66-72, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21416771

RESUMO

Pityriasis alba (PA) is a localized hypopigmented disorder of childhood with many existing clinical variants. It is more often detected in individuals with a darker complexion but may occur in individuals of all skin types. Atopy, xerosis, and mineral deficiencies are potential risk factors. Sun exposure exacerbates the contrast between normal and lesional skin, making lesions more visible and patients more likely to seek medical attention. Poor cutaneous hydration appears to be a common theme for most risk factors and may help elucidate the pathogenesis of this disorder. The end result of this mechanism is inappropriate melanosis manifesting as hypopigmentation. It must be differentiated from other disorders of hypopigmentation, such as pityriasis versicolor alba, vitiligo, nevus depigmentosus, and nevus anemicus. Alleviation of the various risk factors via patient education on proper skin care and hygiene, use of lubricants and emollients, topical corticosteroid therapy in the presence of inflammation, and the novel administration of topical anti-inflammatory drugs such as calcineurin inhibitors can play a crucial role in promoting remission or resolution.


Assuntos
Hipopigmentação/diagnóstico , Pitiríase/diagnóstico , Adolescente , Corticosteroides/uso terapêutico , Inibidores de Calcineurina , Criança , Pré-Escolar , Diagnóstico Diferencial , Emolientes/uso terapêutico , Feminino , Humanos , Hipopigmentação/epidemiologia , Hipopigmentação/etiologia , Hipopigmentação/terapia , Lubrificantes/uso terapêutico , Masculino , Pitiríase/epidemiologia , Pitiríase/etiologia , Pitiríase/terapia , Prognóstico , Terapia Ultravioleta
6.
Cutis ; 103(1): 46-50, 2019 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-30758335

RESUMO

Pityriasis amiantacea (PA) is a hair disorder characterized by matting of multiple hair shafts, typically occurring as an idiopathic condition. A 67-year-old woman with multiple myeloma who developed PA following a bone marrow transplant with melphalan conditioning is described.She noted initial changes in scalp hair regrowth 4 weeks posttransplant. During the next 4 months she developed multiple lesions of PA that rapidly responded to management, including mineral oil under occlusion in the evening followed by daily shampooing with alternating coal tar, salicylic acid, and ketoconazole shampoos. We review medications that have been associated with PA and conditions related to PA, including atopic dermatitis, bacterial infection, fungal infection, psoriasis, and seborrheic dermatitis. Our patient developed PA that was associated with either melphalan conditioning, bone marrow transplant, or both.


Assuntos
Transplante de Medula Óssea/efeitos adversos , Doenças do Cabelo/terapia , Mieloma Múltiplo/terapia , Pitiríase/terapia , Idoso , Feminino , Doenças do Cabelo/etiologia , Humanos , Pitiríase/etiologia
7.
Practitioner ; 257(1765): 28-9, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24367879
8.
Dermatol Clin ; 25(3): 343-52, viii, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17662900

RESUMO

This article addresses pigmentary disorders relevant to India. Many of these disorders are easily spotted because of the Indians' darker complexion. The authors examine hypopigmentary and hyperpigmentary disorders, defining the main characteristics of each and their relevance to the people of India, including social as well as physical ramifications. The authors propose the treatments available to Indians exhibiting these skin disorders.


Assuntos
Transtornos da Pigmentação/classificação , Amiloidose/classificação , Dermatite/classificação , Dermatite Fototóxica/classificação , Dermatite Fototóxica/prevenção & controle , Glucocorticoides/uso terapêutico , Humanos , Imunossupressores/uso terapêutico , Índia , Levamisol/uso terapêutico , Melanose/classificação , Melanose/terapia , Nevo de Ota/classificação , Fotoquimioterapia , Transtornos da Pigmentação/terapia , Pitiríase/classificação , Pitiríase/terapia , Neoplasias Cutâneas/classificação , Luz Solar/efeitos adversos , Vitiligo/classificação , Vitiligo/tratamento farmacológico
9.
Clin Pediatr (Phila) ; 22(3): 200-3, 1983 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-6825364

RESUMO

Pityriasis rosea is a common disorder of unknown etiology that may simulate a number of other dermatologic entities. Secondary syphilis should always be ruled out, particularly in adolescents. Pruritus occurs more frequently than is generally appreciated. The herald patch may not always be present. Secondary lesions occasionally occur distal to the elbows and knees and on the face. Over the more proximal parts of the body the secondary lesions will characteristically align themselves with the long axis following the skin lines of cleavage. The natural course is that of spontaneous resolution within 6 to 8 weeks. Sequelae are rare and usually medically insignificant. Management with oral antipruritics and/or topical steroids may be necessary to relieve the itching.


Assuntos
Pitiríase/diagnóstico , Adolescente , Criança , Diagnóstico Diferencial , Feminino , Humanos , Masculino , Pitiríase/epidemiologia , Pitiríase/patologia , Pitiríase/terapia , Sífilis/diagnóstico , Tinha/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA